The fallopian tube is the culprit and an accomplice in type II ovarian cancer: A review

Tzu Chi Medical Journal

Volumn 25, Issue 4, 2013, Pages 203-205

  Hong, Mun Kun ^a,b   Chu, Tang Yuan ^a,b   Ding, Dah Ching ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Fallopian tube; Ovarian carcinogenesis; Salpingectomy

Indexed keywords

ANGIOGENESIS; CARCINOGENESIS; ECTOPIC PREGNANCY; EPIDEMIOLOGICAL DATA; EPITHELIUM CELL; HUMAN; HYSTERECTOMY; MORTALITY; OVARY CANCER; REVIEW; SALPINGECTOMY; UTERINE TUBE;

EID: 84889087598     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcmj.2013.04.002     Document Type: Review

References (23)

1. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
2. Bell D.A., Scully R.E. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer 1994, 73:1859-1864.
3. Kurman R.J., Shih I.M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008, 27:151-160.
4. Kurman R.J., Shih I.M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010, 34:433-443.
5. Narod S.A., Sun P., Ghadirian P., Lynch H., Isaacs C., Garber J., et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet 2001, 357:1467-1470.
6. Jenks S. Tying fallopian tubes to ovarian cancer risk. JNatl Cancer Inst 2012, 104:578-579.
7. Rice M.S., Murphy M.A., Tworoger S.S. Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis. JOvarian Res 2012, 5:13.
8. Tsilidis K.K., Allen N.E., Key T.J., Dossus L., Lukanova A., Bakken K., et al. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2011, 105:1436-1442.
9. Pieta B., Chmaj-Wierzchowska K., Opala T. Past obstetric history and risk of ovarian cancer. Ann Agric Environ Med 2012, 19:385-388.
10. Tung K.H., Goodman M.T., Wu A.H., McDuffie K., Wilkens L.R., Kolonel L.N., et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 2003, 158:629-638.
11. Sueblinvong T., Carney M.E. Current understanding of risk factors for ovarian cancer. Curr Treat Options Oncol 2009, 10:67-81.
12. Hemminki K., Granstrom C. Familial clustering of ovarian and endometrial cancers. Eur J Cancer 2004, 40:90-95.
13. Kashyap S., Moher D., Fung M.F., Rosenwaks Z. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol 2004, 103:785-794.
14. Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J.E., et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004, 82:405-414.
15. Vang R., Shih I.M., Kurman R.J. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 2013, 62:44-58.
16. Seidman J.D., Zhao P., Yemelyanova A. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol 2011, 120:470-473.
17. Lee Y., Miron A., Drapkin R., Nucci M.R., Medeiros F., Saleemuddin A., et al. Acandidate precursor to serous carcinoma that originates in the distal fallopian tube. JPathol 2007, 211:26-35.
18. Marquez R.T., Baggerly K.A., Patterson A.P., Liu J., Broaddus R., Frumovitz M., et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 2005, 11:6116-6126.
19. Laury A.R., Ning G., Quick C.M., Bijron J., Parast M.M., Betensky R.A., et al. Fallopian tube correlates of ovarian serous borderline tumors. Am J Surg Pathol 2011, 35:1759-1765.
20. Chen E.Y., Mehra K., Mehrad M., Ning G., Miron A., Mutter G.L., et al. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the fallopian tube. JPathol 2010, 222:110-116.
21. Roh M.H., Yassin Y., Miron A., Mehra K.K., Mehrad M., Monte N.M., et al. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol 2010, 23:1316-1324.
22. Kim J., Coffey D.M., Creighton C.J., Yu Z., Hawkins S.M., Matzuk M.M. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci U S A 2012, 109:3921-3926.
23. Kurman R.J., Shih I.M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm. Hum Pathol 2011, 42:918-931.